US Stock MarketDetailed Quotes

SLGL Sol-Gel Technologies

Watchlist
  • 0.556
  • +0.046+9.00%
Close Nov 4 16:00 ET
15.49MMarket Cap-1029P/E (TTM)

About Sol-Gel Technologies Company

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Company Profile

SymbolSLGL
Company NameSol-Gel Technologies
Listing DateFeb 1, 2018
Issue Price12.00
Founded1997
CEODr. Alon Seri-Levy
MarketNASDAQ
Employees36
Fiscal Year Ends12-31
AddressWeizmann Science Park,7 Golda Meir Street
CityNess Ziona
ProvinceTel Aviv
CountryIsrael
Zip Code74036
Phone972-8-931-3433

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Alon Seri-Levy
  • Chief Executive Officer and Director
  • 1.20M
  • Gilad Mamlok
  • Chief Financial Officer
  • 643.00K
  • Dr. Itzik Yosef
  • Chief Operating Officer
  • 288.00K
  • Dr. Karine Neimann
  • Vice President, Projects and Planning and Chief Chemist
  • --
  • Dr. Ofra Levy-Hacham
  • Vice President Clinical, Regulatory Affairs and Quality
  • 4.02M
  • Tamar Fishman Jutkowitz
  • Vice President and General Counsel
  • --
  • Michael Glezin
  • Vice President, Business Development
  • --
  • Dr. Ofer Toledano
  • Vice President, Research and Development
  • 482.00K
  • Moshe Arkin
  • Executive Chairman of the Board
  • --
  • Hani Lerman
  • Director
  • --
  • Itai Arkin
  • Director
  • --
  • Sharon Kochan
  • Director
  • --
  • Ran Gottfried
  • Lead Independent Director
  • --
  • Jerrold S. Gattegno
  • Independent Director
  • --
  • Yuval Yanai
  • Independent Director
  • --
  • Jonathan B. Siegel
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data